Condition
Ear Deformities, Acquired
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed1
Terminated1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07154667Not ApplicableRecruiting
Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
NCT03624608Not ApplicableTerminatedPrimary
Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
NCT03100604Not ApplicableCompletedPrimary
The Effect of General Anesthesia on the Middle Ear Pressure
Showing all 3 trials